Hospitals Preparing for Surge of Summer Births With Support From US Med-Equip
HOUSTON, TX / ACCESSWIRE / May 9, 2024 / As hospitals prepare for the summer months, a period traditionally marked...
News
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic...
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic...
Halberd’s Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously.JACKSON CENTER,...
Halberd’s Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously.JACKSON CENTER,...
Action Behavior Centers and Austin’s JW Marriott Partner Host Community Impact Event With The Make-A-Wish Foundation
AUSTIN, TX / ACCESSWIRE / May 9, 2024 / Action Behavior Centers, a leading provider of applied behavior analysis (ABA)...
Action Behavior Centers and Austin’s JW Marriott Partner Host Community Impact Event With The Make-A-Wish Foundation
AUSTIN, TX / ACCESSWIRE / May 9, 2024 / Action Behavior Centers, a leading provider of applied behavior analysis (ABA)...
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global Market
PYEONGCHANG, SOUTH KOREA / ACCESSWIRE / May 9, 2024 / Mediprogen Inc., a company that produces purified protein for the...
Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global Market
PYEONGCHANG, SOUTH KOREA / ACCESSWIRE / May 9, 2024 / Mediprogen Inc., a company that produces purified protein for the...
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on...
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on...
Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESCALGARY, AB / ACCESSWIRE / May 8, 2024...
Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESCALGARY, AB / ACCESSWIRE / May 8, 2024...
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company...
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE /...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE /...
Isto Biologics Unveils Fibrant Liberty(TM): An Advanced Allograft Solution Designed for Rapid and Consistent Hydration
The newest addition to the Fibrant product lineHOPKINTON, MA / ACCESSWIRE / May 8, 2024 / Isto Biologics, a global...